FDA Approved: MITOXANTRONE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for mitoxantrone hydrochloride, submitted by Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Multiple Sclerosis
• Non-hodgkin Lymphoma
• Prostate Cancer

Drugs mentioned

• Mitoxantrone hydrochloride (mitoxantrone)

Snippet

SUPPL AP for MITOXANTRONE (MITOXANTRONE HYDROCHLORIDE)